Kobane står i brand, och trycket ökar på Turkiet att ta en mer aktiv roll i kriget mot Islamiska staten. Bland kurderna kokar de upprörda känslorna över vad man ser som turkisk passivitet och många har dött i de senaste veckornas protester. I den kurddominerade staden Diyarbakir anklagar borgmästaren Turkiets president för att indirekt stödja extremisterna inom IS.
oxide7 (1013325) writes "In June 2011, Julian Assange received an unusual visitor: the chairman of Google, Eric Schmidt. They outlined radically opposing perspectives: for Assange, the liberating power of the Internet is based on its freedom and statelessness. For Schmidt, emancipation is at one with U.S. foreign policy objectives and is driven by connecting non-Western countries to Western companies and markets. These differences embodied a tug-of-war over the Internet's future that has only gathered force subsequently. Assange describes his encounter with Schmidt and how he came to conclude that it was far from an innocent exchange of views."
Rättvisan hann före döden - nätt och jämnt. En 91-åring som beskrivits som hjärnan bakom systematiska illdåd under Bangladesh självständighetskrig 1971 har avlidit i fängelse, ett drygt år efter att ha dömts för brott mot mänskligheten.
Ebolaepidemin i Sierra Leone ska vara under kontroll innan årsskiftet, säger landets president. Samtidigt meddelar WHO att smittan inte verkar spridas till grannländerna.
När Helen Sarkisian, 46, från Stockholm återvände till Sverige från det eboladrabbade Sierra Leone trodde hon att faran var över. I stället träffades hon av den svenska ebolaskräcken.
sciencehabit writes Extensive background documents from a meeting that took place today at the World Health Organization (WHO) have provided new details about exactly what it will take to test, produce, and bankroll Ebola vaccines, which could be a potential game changer in the epidemic. ScienceInsider obtained materials that vaccinemakers, governments, and WHO provided to the 100 or so participants at a meeting on 'access and financing' of Ebola vaccines. The documents put hard numbers on what until now have been somewhat fuzzy academic discussions. And they make clear to the attendees—who include representatives from governments, industry, philanthropies, and nongovernmental organizations—that although testing and production are moving forward at record speed, knotty issues remain.